Carcinoma

Atezolizumab plus a modified docetaxel, cisplatin and 5-fluorouracilregimen is a safe and effective first-line treatment for locally advanced squamous cell anal carcinoma, according to research presented at 2022 ASCO Annual Meeting.

The most common type of cancer in humans is carcinoma.

Noninvasive diagnostic methods such as dermoscopy and confocal reflectance microscopy may have utility in minimizing biopsy use in predicting progression of actinic keratosis to carcinoma, according to a study.

The FDA granted regular approval to the combination of pembrolizumab and lenvatinib for certain women with advanced endometrial carcinoma that is not microsatellite instability-high or mismatch repair deficient.

Mortality associated with Merkle cell carcinoma may be lower among women compared with men, according to a retrospective study.

Anal carcinoma risk was significantly higher among individuals with HIV and a history of anal or genital warts than among those with no history of these warts, according to a study.

Adjuvant nivolumab significantly prolonged DFS compared with placebo for patients with high-risk, muscle-invasive urothelial carcinoma, according to topline data released by the agent’s manufacturer.